DOCSLIB.ORG

Cell Receptor Senescence Response by an Endosomal NK Activated Kinase 1 Control Signals for A

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cell Receptor Senescence Response by an Endosomal NK Activated Kinase 1 Control Signals for A The Journal of Immunology TNFR-Associated Factor 6 and TGF-b–Activated Kinase 1 Control Signals for a Senescence Response by an Endosomal NK Cell Receptor Sumati Rajagopalan, Elizabeth C. Lee, Matthew L. DuPrie, and Eric O. Long The endosomal innate receptor CD158d (killer cell Ig-like receptor 2DL4) induces cellular senescence in human NK cells in response to soluble ligand (HLA-G or agonist Ab). These senescent NK cells display a senescence-associated secretory phenotype, and their secretome promotes vascular remodeling and angiogenesis. To understand how CD158d initiates signaling for a senescence response, we mapped the region in its cytoplasmic tail that controls signaling. We identified a conserved TNFR-associated factor 6 (TRAF6) binding motif, which was required for CD158d-induced NF-kB activation and IL-8 secretion, TRAF6 association with CD158d, and TRAF6 recruitment to CD158d+ endosomes in transfected cells. The adaptor TRAF6 is known to couple proximal signals from receptors such as endosomal TLRs and CD40 through the kinase TGF-b–activated kinase 1 (TAK1) for NF-kB–dependent proinflammatory responses. Small interfering RNA–mediated silencing of TRAF6 and TAK1, and inhibition of TAK1 blocked CD158d-dependent IL-8 secretion. Stimulation of primary, resting NK cells with soluble Ab to CD158d induced TRAF6 associ- ation with CD158d, induced TAK1 phosphorylation, and inhibition of TAK1 blocked the CD158d-dependent reprogramming of NK cells that produces the senescence-associated secretory phenotype signature. Our results reveal that a prototypic TLR and TNFR signaling pathway is used by a killer cell Ig-like receptor that promotes secretion of proinflammatory and proangiogenic mediators as part of a unique senescence phenotype in NK cells. The Journal of Immunology, 2014, 192: 714–721. atural killer cells carry out their effector functions through of fetal trophoblast cells by responding to HLA-G, a nonclassical their cytolytic activity and cytokine secretion and have MHC molecule produced by these fetal cells in the early weeks of N important roles in immune defense and in reproduction pregnancy (8). Endosomal signaling for a senescence response and (1, 2). CD158d (killer cell Ig-like receptor [KIR]2DL4) is a unique sustained SASP may promote the vascular remodeling required for member of the KIR family and expressed by all NK cells and successful placentation. In support of this, a senescence signature was a subset of T cells (3). Unlike most other KIR family members that seen in a retrospective analysis of microarrays of decidual NK cells are expressed at the cell surface, CD158d resides primarily in endo- isolated from first-trimester abortions that were compared with pe- by guest on October 1, 2021. Copyright 2013 Pageant Media Ltd. somes, from where it generates proinflammatory/proangiogenic ripheral blood NK cells (6, 9). signals in response to its ligand, soluble HLA-G (4). A signaling How CD158d initiates NF-kB signaling for a senescence re- cascade involving the DNA damage kinase DNA-dependent protein sponse is not known. In this study, we show that a short stretch of kinase, catalytic subunit, Akt, and NF-kB is initiated upon CD158d amino acids in the cytoplasmic tail of CD158d recruits the adaptor engagement (5). This endosomal signaling results in the induction TNFR-associated factor 6 (TRAF6), which is an essential node in of cellular senescence in primary, resting NK cells and the produc- TLR signaling. We demonstrate that this recruitment of TRAF6 tion of a characteristic senescence-associated secretory phenotype regulates NF-kB signaling in response to KIR2DL4 and that its (SASP) (6). The secretome of these metabolically active senescent interacting partner kinase TAK1 (TGF-b–activated kinase 1) is re- NK cells contain factors, including cytokines and chemokines, that quired for the senescence response induced by KIR2DL4. Thus, we http://classic.jimmunol.org promote vascular remodeling and angiogenesis. NK cell repro- show the unexpected usage of signaling effectors of the TLR family gramming toward an SASP has implications at sites of HLA-G ex- by an endosomal innate immune receptor on NK cells. pression, such as in early pregnancy and certain tumors (7). NK cells, which are abundant at the implantation site, may sense the invasion Materials and Methods Cell culture HEK293T cells were obtained from American Type Culture Collection and Downloaded from Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, cultured in DMEM containing 10% FBS. Cells were transiently transfected National Institutes of Health, Rockville, MD 20852 using Lipofectamine 2000 (Invitrogen), according to the manufacturer’s Received for publication September 6, 2013. Accepted for publication November 10, instructions. 293T–2DL4-GFP cells are HEK293T cells that were stably 2013. transfected with a plasmid encoding a fusion protein of 2DL4 and GFP (4). This work was supported by the Intramural Research Program of the National Insti- Human polyclonal NK cells were isolated from PBLs from anonymous tute of Allergy and Infectious Diseases, National Institutes of Health. donors at the National Institutes of Health (NIH) Department of Trans- fusion Medicine, under an NIH Institutional Review Board–approved pro- Address correspondence and reprint requests to Dr. Eric O. Long, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National tocol, with informed consent. NK cells were isolated using the Negative Institutes of Health, Twinbrook II/201E, 12441 Parklawn Drive, Rockville, MD Selection Human NK Cell Enrichment Kit (Stem Cell Technologies). NK 2 + 20852. E-mail address: [email protected] cells were .97% CD3 and CD56 . Freshly isolated NK cells (resting NK) were cultured in Iscove’s modified DMEM containing 10% human Abbreviations used in this article: Ac, acidic; Ar, aromatic; cIgG, control IgG; cIgM, control IgM; KIR, killer cell Ig-like receptor; NIH, National Institutes of Health; serum without added IL-2 or feeders. Resting NK cells were incubated PBST, PBS plus 0.1% Tween-20; PCC, Pearson correlation coefficient; SASP, with control IgG1 (MOPC21) or agonist anti-KIR2DL4 (mAb #33) at senescence-associated secretory phenotype; siRNA, small interfering RNA; TAK1, 10 mg/ml for 16 h. NKL cells (a gift from M. Robertson, Indiana School TGF-b–activated kinase 1; TRAF6, TNFR-associated factor 6; wt, wild-type. of Medicine, Indianapolis, IN) were cultured in RPMI 1640 medium www.jimmunol.org/cgi/doi/10.4049/jimmunol.1302384 The Journal of Immunology 715 containing 10% FCS, 1% glutamine, 1% sodium pyruvate, and 200 U/ml Pearson value of zero indicates no colocalization, whereas a value of one rIL-2. NKL cells were rested for 48 h in the absence of IL-2 and in reduced indicates perfect colocalization of all pixels. FCS (2%) prior to stimulation with anti-2DL4 Abs. RNA interference Abs and reagents HEK293T cells were transfected with small interfering RNAs (siRNAs; The following Abs were used: anti-TRAF6: H-274 (used for immuno- Dharmacon) at a final concentration of 100 nM using Lipofectamine 2000 blotting and immunocytochemistry) and D-10 (used for immunoprecipi- (Invitrogen). The siRNAs used were: ON-TARGETplus SMARTpool siRNA tation); HRP-conjugated anti-rabbit and anti-mouse Abs from Santa Cruz (consists of four individual siRNA oligonucleotides) for TRAF6 and TAK1, Biotechnology; anti-actin Ab from BD Biosciences; Alexa Fluor 488– ON-TARGETplus individual siRNA duplexes for TRAF6 (J-004712-09-0005) conjugated anti-HA (6E2), anti-TAK1, anti–phospho-TAK1 (Thr187), and TAK1 (J-003790-19-0005), and two custom synthesized individual siR- anti–phospho-p38 MAPK (Thr180/Tyr182), anti–phospho-IkBa (Ser32/36), NAs for Triad3A (Triad3A siRNA #1: sense, 59-AAGUGCUCAGUAGU- and anti-MOPC21 Abs from Cell Signaling Technology; anti-KIR2DL4 CAGGACAUU-39 and antisense, 59-UGUCCUGACUACUGAGCACUUUU- mAb (MAB2238) from R&D Systems; anti-KIR2DL4 mAbs #33 (IgG1), 39; Triad3A siRNA #2: sense, 59-UCUGGACCGAUCCCACUGAAUU-39 and #36 (IgM), and #64 (IgM) were produced in our laboratory (10); anti-HA antisense, 59-UUCAGUGGGAUCGGUCCAGAUU-39). ON-TARGETplus and Alexa Fluor 594–conjugated anti-HA (16B12) Abs from Covance; nontargeting siRNA pool (consists of four individual nontargeting siRNAs) anti-GFP and anti-rabbit Alexa Fluor 564 Abs from Molecular Probes; was used as a negative control in all siRNA experiments. Forty-eight hours and anti-Triad3A Ab from Abcam. HRP-conjugated Protein-A was from BD after transfection with siRNA, HEK293T cells were transfected with 0.5 mg Biosciences and was used for Western blot detection of immunoprecipitated 2DL4 plasmid DNA. At 24 h after 2DL4 transfection and 72 h from the start cell extracts. For immunocytochemistry experiments, ProLong Anti-fade kit of siRNA transfection, the culture medium was tested for the production of and Image-iT FX Signal Enhancer (used to improve signal-to-noise ratio of IL-8 by ELISA. Cell lysates from the siRNA-transfected cells were analyzed immunolabeled cells) were purchased from Molecular Probes. TAK1 in- by immunoblotting to assess knockdown efficiency of target proteins. hibitor (5Z)-7-Oxozeaenol was obtained from Tocris Bioscience. Immunoprecipitation and immunoblotting Molecular constructs Cells were washed with ice-cold PBS and lysed in 1% Nonidet P-40 lysis The HA-tagged wild-type (wt) 2DL4 in the pDisplay vector (Stratagene) buffer containing 50 mM Tris, 140 mM NaCl, and protease-inhibitor was previously described (4). Mutations in the cytoplasmic tail of 2DL4 mixture (Roche). Cell lysates were precleared with control IgG (cIgG) were generated from the pDisplay-2DL4 expression vector using a Stra- and protein G-agarose beads for 1 h, followed by incubation with various tagene Quick Change site-directed mutagenesis kit according to the Abs at 4˚C. Protein G-agarose beads were then added and allowed to bind manufacturer’s instructions. The following primers were used: forward, for 1 h at 4˚C. Immunoprecipitates were collected by brief centrifuga- 59-GAGGACTCTGATGAAGCAGACCCTCAGGAGGTG-39 and reverse, tion, washed six times, and eluted by boiling in 23 LDS sample buffer 59-CACCTCCTGAGGGTCTGCTTCATCAGAGTCCTC-39 to generate a (Invitrogen).
Load more

Recommended publications
  • Cellular Senescence Promotes Skin Carcinogenesis Through P38mapk and P44/P42mapk Signaling
    Author Manuscript Published OnlineFirst on July 8, 2020; DOI: 10.1158/0008-5472.CAN-20-0108 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Cellular senescence promotes skin carcinogenesis through p38MAPK and p44/p42 MAPK signaling Fatouma Alimirah1, Tanya Pulido1, Alexis Valdovinos1, Sena Alptekin1,2, Emily Chang1, Elijah Jones1, Diego A. Diaz1, Jose Flores1, Michael C. Velarde1,3, Marco Demaria1,4, Albert R. Davalos1, Christopher D. Wiley1, Chandani Limbad1, Pierre-Yves Desprez1, and Judith Campisi1,5* 1Buck Institute for Research on Aging, Novato, CA 94945, USA 2Dokuz Eylul University School of Medicine, Izmir 35340, Turkey 3Institute of Biology, University of the Philippines Diliman, College of Science, Quezon City 1101, Philippines 4European Research Institute for the Biology of Ageing, University Medical Center Groningen, Groningen, the Netherlands 5Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA *Lead Contact: Judith Campisi, Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, CA 94945, USA; Email: [email protected] or [email protected]. Telephone: 1-415-209-2066; Fax: 1-415-493-3640 Running title: Senescence and skin carcinogenesis Key words: doxorubicin, senescence-associated secretory phenotype, squamous cell carcinoma, microenvironment, inflammation, transgenic mice, tumorspheres Conflict of Interests JC is a co-founder of Unity Biotechnology and MD owns equity in Unity Biotechnology. All other authors declare no competing financial interests. Downloaded from cancerres.aacrjournals.org on September 25, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on July 8, 2020; DOI: 10.1158/0008-5472.CAN-20-0108 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Cellular Senescence: Friend Or Foe to Respiratory Viral Infections?
    Early View Perspective Cellular Senescence: Friend or Foe to Respiratory Viral Infections? William J. Kelley, Rachel L. Zemans, Daniel R. Goldstein Please cite this article as: Kelley WJ, Zemans RL, Goldstein DR. Cellular Senescence: Friend or Foe to Respiratory Viral Infections?. Eur Respir J 2020; in press (https://doi.org/10.1183/13993003.02708-2020). This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Copyright ©ERS 2020. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. Cellular Senescence: Friend or Foe to Respiratory Viral Infections? William J. Kelley1,2,3 , Rachel L. Zemans1,2 and Daniel R. Goldstein 1,2,3 1:Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA 2:Program in Immunology, University of Michigan, Ann Arbor, MI, USA 3:Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI USA Email of corresponding author: [email protected] Address of corresponding author: NCRC B020-209W 2800 Plymouth Road Ann Arbor, MI 48104, USA Word count: 2750 Take Home Senescence associates with fibrotic lung diseases. Emerging therapies to reduce senescence may treat chronic lung diseases, but the impact of senescence during acute respiratory viral infections is unclear and requires future investigation. Abstract Cellular senescence permanently arrests the replication of various cell types and contributes to age- associated diseases.
    [Show full text]
  • Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases
    cells Review Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases Ping Song * , Junqing An and Ming-Hui Zou Center for Molecular and Translational Medicine, Georgia State University, 157 Decatur Street SE, Atlanta, GA 30303, USA; [email protected] (J.A.); [email protected] (M.-H.Z.) * Correspondence: [email protected]; Tel.: +1-404-413-6636 Received: 29 January 2020; Accepted: 5 March 2020; Published: 10 March 2020 Abstract: Senescent cells are generally characterized by permanent cell cycle arrest, metabolic alteration and activation, and apoptotic resistance in multiple organs due to various stressors. Excessive accumulation of senescent cells in numerous tissues leads to multiple chronic diseases, tissue dysfunction, age-related diseases and organ ageing. Immune cells can remove senescent cells. Immunaging or impaired innate and adaptive immune responses by senescent cells result in persistent accumulation of various senescent cells. Although senolytics—drugs that selectively remove senescent cells by inducing their apoptosis—are recent hot topics and are making significant research progress, senescence immunotherapies using immune cell-mediated clearance of senescent cells are emerging and promising strategies to fight ageing and multiple chronic diseases. This short review provides an overview of the research progress to date concerning senescent cell-caused chronic diseases and tissue ageing, as well as the regulation of senescence by small-molecule drugs in clinical trials and different roles and regulation of immune cells in the elimination of senescent cells. Mounting evidence indicates that immunotherapy targeting senescent cells combats ageing and chronic diseases and subsequently extends the healthy lifespan. Keywords: cellular senescence; senescence immunotherapy; ageing; chronic disease; ageing markers 1.
    [Show full text]
  • Cellular Senescence and Inflammaging in the Skin Microenvironment
    International Journal of Molecular Sciences Review Cellular Senescence and Inflammaging in the Skin Microenvironment Young In Lee 1,2 , Sooyeon Choi 1, Won Seok Roh 1 , Ju Hee Lee 1,2,* and Tae-Gyun Kim 1,* 1 Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul 107-11, Korea; [email protected] (Y.I.L.); [email protected] (S.C.); [email protected] (W.S.R.) 2 Scar Laser and Plastic Surgery Center, Yonsei Cancer Hospital, Yonsei University College of Medicine, Seoul 107-11, Korea * Correspondence: [email protected] (J.H.L.); [email protected] (T.-G.K.); Tel.: +82-2-2228-2080 (J.H.L. & T.-G.K.) Abstract: Cellular senescence and aging result in a reduced ability to manage persistent types of inflammation. Thus, the chronic low-level inflammation associated with aging phenotype is called “inflammaging”. Inflammaging is not only related with age-associated chronic systemic diseases such as cardiovascular disease and diabetes, but also skin aging. As the largest organ of the body, skin is continuously exposed to external stressors such as UV radiation, air particulate matter, and human microbiome. In this review article, we present mechanisms for accumulation of senescence cells in different compartments of the skin based on cell types, and their association with skin resident immune cells to describe changes in cutaneous immunity during the aging process. Keywords: inflammaging; senescence; skin; fibroblasts; keratinocytes; melanocytes; immune cells Citation: Lee, Y.I.; Choi, S.; Roh, W.S.; Lee, J.H.; Kim, T.-G. Cellular Senescence and Inflammaging in the 1.
    [Show full text]
  • Cellular Senescence and Apoptosis: How Cellular Responses Might Influence Aging Phenotypes
    Experimental Gerontology 38 (2003) 5–11 www.elsevier.com/locate/expgero Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes Judith Campisia,b,* aLife Sciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, USA bBuck Institute for Age Research, 8001 Redwood Blvd., Novato, CA 94945, USA Received 20 May 2002; accepted 28 May 2002 Abstract Aging in complex multi-cellular organisms such as mammals entails distinctive changes in cells and molecules that ultimately compromise the fitness of adult organisms. These cellular and molecular changes lead to the phenotypes we recognize as aging. This review discusses some of the cellular and molecular changes that occur with age, specifically changes that occur as a result of cellular responses that evolved to ameliorate the inevitable damage that is caused by endogenous and environmental insults. Because the force of natural selection declines with age, it is likely that these processes were never optimized during their evolution to benefit old organisms. That is, some age- related changes may be the result of gene activities that were selected for their beneficial effects in young organisms, but the same gene activities may have unselected, deleterious effects in old organisms, a phenomenon termed antagonistic pleiotropy. Two cellular processes, apoptosis and cellular senescence, may be examples of antagonistic pleiotropy. Both processes are essential for the viability and fitness of young organisms, but may contribute to aging phenotypes, including certain age-related diseases. q 2002 Elsevier Science Inc. All rights reserved. Keywords: Antagonistic pleiotropy; Apoptosis; Cancer; Cellular senescence; DNA damage response; Neurodegeneration; p53; Telomeres 1.
    [Show full text]
  • Werner and Hutchinson–Gilford Progeria Syndromes: Mechanistic Basis of Human Progeroid Diseases
    REVIEWS MECHANISMS OF DISEASE Werner and Hutchinson–Gilford progeria syndromes: mechanistic basis of human progeroid diseases Brian A. Kudlow*¶, Brian K. Kennedy* and Raymond J. Monnat Jr‡§ Abstract | Progeroid syndromes have been the focus of intense research in part because they might provide a window into the pathology of normal ageing. Werner syndrome and Hutchinson–Gilford progeria syndrome are two of the best characterized human progeroid diseases. Mutated genes that are associated with these syndromes have been identified, mouse models of disease have been developed, and molecular studies have implicated decreased cell proliferation and altered DNA-damage responses as common causal mechanisms in the pathogenesis of both diseases. Progeroid syndromes are heritable human disorders with therefore termed segmental, as opposed to global, features that suggest premature ageing1. These syndromes progeroid syndromes. Among the segmental progeroid have been well characterized as clinical disease entities, syndromes, the syndromes that most closely recapitu- and in many instances the associated genes and causative late the features of human ageing are Werner syndrome mutations have been identified. The identification of (WS), Hutchinson–Gilford progeria syndrome (HGPS), genes that are associated with premature-ageing-like Cockayne syndrome, ataxia-telangiectasia, and the con- syndromes has increased our understanding of molecu- stitutional chromosomal disorders of Down, Klinefelter lar pathways that protect cell viability and function, and
    [Show full text]
  • Cellular Senescence in the Kidney
    REVIEW www.jasn.org Cellular Senescence in the Kidney Marie-Helena Docherty,1 Eoin D. O’Sullivan,1,2 Joseph V. Bonventre,3 and David A. Ferenbach1,2 1Department of Renal Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK; 2Centre for Inflammation Research, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, UK; and 3Renal Division and Division of Engineering in Medicine, Brigham and Women’s Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts ABSTRACT Senescent cells have undergone permanent growth arrest, adopt an altered secre- to induce growth arrest and senescence in tory phenotype, and accumulate in the kidney and other organs with ageing and vitro, the key importance of telomere short- injury. Senescence has diverse physiologic roles and experimental studies support eninginhumanagingislesswellestab- its importance in nephrogenesis, successful tissue repair, and in opposing malignant lished, and is not the focus of this review.5 transformation. However, recent murine studies have shown that depletion of Although the association between aging chronically senescent cells extends healthy lifespan and delays age-associated and senescence is well recognized,6,7 only disease—implicating senescence and the senescence-associated secretory phenotype recently have experiments depleting senes- as drivers of organ dysfunction. Great interest is therefore focused on the manipu- cent cells in murine models been shown to lation of senescence as a novel therapeutic target in kidney disease. In this review, postpone the onset of age-related diseases we examine current knowledge and areas of ongoing uncertainty regarding senes- and extend healthy lifespan, reigniting clin- cence in the human kidney and experimental models. We summarize evidence sup- ical and research interest.8–10 porting the role of senescence in normal kidney development and homeostasis but also senescence-induced maladaptive repair, renal fibrosis, and transplant failure.
    [Show full text]
  • AP-1 Imprints a Reversible Transcriptional Program of Senescent Cells
    bioRxiv preprint doi: https://doi.org/10.1101/633594; this version posted May 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. AP-1 Imprints a Reversible Transcriptional Program of Senescent Cells Ricardo Iván Martínez-Zamudio1,5,8, Pierre-François Roux1,5, José Américo N L F de Freitas1,4, Lucas Robinson1,4, Gregory Doré1, Bin Sun6,7, Jesús Gil6,7, Utz Herbig8 and Oliver Bischof1,2,3,9* 1 Institut Pasteur, Laboratory of Nuclear Organization and Oncogenesis, Department of Cell Biology and Infection, 75015 Paris, France 2 INSERM, U993, 75015 Paris, France 3 Equipe Labellisée Fondation ARC pour la recherche sur le cancer, Paris, France 4 Université de Paris, Sorbonne Paris Cité, Paris, France 5 These authors contributed equally to this work 6 MRC London Institute of Medical Sciences (LMS), Du Cane Road, London, W12 0NN, UK. 7 Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK. 8 Department of Microbiology, Biochemistry & Molecular Genetics, Rutgers Biomedical & Health Sciences, Rutgers University, 205 South Orange Avenue, Newark, NJ 07103, USA 9 Lead contact *Correspondence: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/633594; this version posted May 9, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. SUMMARY Senescent cells play important physiological- and pathophysiological roles in tumor suppression, tissue regeneration, and aging.
    [Show full text]
  • Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
    cells Review Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy Francisco Triana-Martínez, María Isabel Loza and Eduardo Domínguez * Biofarma Research Group, Center for Research in molecular Medicine and Chronic Diseases (CIMUS), Universidad de Santiago de Compostela, Avenida de Barcelona s/n, 15782 Santiago de Compostela, Spain; [email protected] (F.T.-M.); [email protected] (M.I.L.) * Correspondence: [email protected]; Tel.: +34-88-1815-484 Received: 20 December 2019; Accepted: 29 January 2020; Published: 3 February 2020 Abstract: Here, we provide an overview of the importance of cellular fate in cancer as a group of diseases of abnormal cell growth. Tumor development and progression is a highly dynamic process, with several phases of evolution. The existing evidence about the origin and consequences of cancer cell fate specification (e.g., proliferation, senescence, stemness, dormancy, quiescence, and cell cycle re-entry) in the context of tumor formation and metastasis is discussed. The interplay between these dynamic tumor cell phenotypes, the microenvironment, and the immune system is also reviewed in relation to cancer. We focus on the role of senescence during cancer progression, with a special emphasis on its relationship with stemness and dormancy. Selective interventions on senescence and dormancy cell fates, including the specific targeting of cancer cell populations to prevent detrimental effects in aging and disease, are also reviewed. A new conceptual framework about the impact of synthetic lethal strategies by using senogenics and then senolytics is given, with the promise of future directions on innovative anticancer therapies. Keywords: cellular senescence; stemness; dormancy; quiescence; senolytic 1.
    [Show full text]
  • Cellular Senescence
    infoaging guides BIOLOGY OF AGING CELLULAR SENESCENCE An introduction to aging science brought to you by the American Federation for Aging Research WHAT IS CELLULAR no longer divide become what is that activate oncogenes—normal SENESCENCE? called “senescent.” Cells taken cellular genes that, when mutated, from older humans generally have contribute to the development Cellular senescence is a process shorter telomeres than cells from of cancer. These diverse triggers associated with aging that occurs young humans, so cells from older support the idea that cellular at the level of our cells. Cellular humans generally divide fewer senescence evolved primarily to senescence is sometimes called times before becoming replica- protect organisms from cancer. replicative senescence. Forty years tively senescent. ago, Dr. Leonard Hayflick and his Scientists have also noted that colleague, Dr. Paul Moorhead, Critically short telomeres, which senescent cells are different from discovered that many human resemble broken chromosomes, their younger counterparts. Like cells—particularly fibroblast cells, are not the only causes of ”senes- older people themselves, cells ap- which secrete substances that cence,” and so scientists often proaching senescence incur many provide structure to tissues—had use the more general term ”cellular biological losses or take on new a limited capacity to reproduce senescence.” Cellular senescence functions. Where younger cells themselves in culture by dividing. produce structural or functional They found that these and many proteins that maintain tissues in other normal human cells derived a healthy state, cells approaching from fetal, embryonic, or newborn senescence release enzymes that tissue can undergo between 40 break down these proteins. and 60 cell divisions, but then can divide no more.
    [Show full text]
  • Evidence of Oncogene-Induced Senescence in Thyroid Carcinogenesis
    Endocrine-Related Cancer (2011) 18 743–757 Evidence of oncogene-induced senescence in thyroid carcinogenesis Maria Grazia Vizioli, Patricia A Possik1, Eva Tarantino2, Katrin Meissl1, Maria Grazia Borrello, Claudia Miranda, Maria Chiara Anania, Sonia Pagliardini, Ettore Seregni3, Marco A Pierotti4, Silvana Pilotti2, Daniel S Peeper 1 and Angela Greco Molecular Mechanisms Unit, Department of Experimental Oncology and Molecular Medicine, IRCCS Foundation - Istituto Nazionale dei Tumori, Via G. Amadeo, 42 20133 Milan, Italy 1Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan, 121 1066CX Amsterdam, The Netherlands 2Department of Pathology, 3Nuclear Medicine Division, Department of Diagnostic Imaging and Radiotherapy and 4Scientific Directorate, IRCCS Foundation - Istituto Nazionale dei Tumori, Via G. Venezian, 1 20133 Milan, Italy (Correspondence should be addressed to A Greco; Email: [email protected]) Abstract Oncogene-induced senescence (OIS) is a growth arrest triggered by the enforced expression of cancer-promoting genes and acts as a barrier against malignant transformation in vivo. In this study, by a combination of in vitro and in vivo approaches, we investigate the role of OIS in tumours originating from the thyroid epithelium. We found that expression of different thyroid tumour-associated oncogenes in primary human thyrocytes triggers senescence, as demon- strated by the presence of OIS hallmarks: changes in cell morphology, accumulation of SA-b-Gal and senescence-associated heterochromatic foci, and upregulation of transcription of the cyclin- dependent kinase inhibitors p16INK4a and p21CIP1. Furthermore, immunohistochemical analysis of a panel of thyroid tumours characterised by different aggressiveness showed that the expression of OIS markers such as p16INK4a, p21CIP1 and IGFBP7 is upregulated at early stages, and lost during thyroid tumour progression.
    [Show full text]
  • Stress-Induced Cellular Senescence Contributes to Chronic Inflammation and Cancer Progression
    Current knowledge of molecular and cellular biology of cellular senescence・ S. Kobashigawa et al. Review Thermal Med, 35 (4): 41-58, 2019. Stress-induced Cellular Senescence Contributes to Chronic Inflammation and Cancer Progression SHINKO KOBASHIGAWA1,2, YOSHIHIKO M. SAKAGUCHI1, SHINICHIRO MASUNAGA2, EIICHIRO MORI1* 1Department of Future Basic Medicine, Nara Medical University, Kashihara, Nara, 634-8521, Japan 2Kyoto University, Institute of Integrated Radiation and Nuclear Science, Kumatori, Osaka, 590-0494, Japan Abstract: Cellular senescence has long been considered to act as a tumor suppressor or tumor suppression mechanism and described as a phenomenon of irreversible cell cycle arrest. Cellular senescence, however, is now considered to have physiological functions other than tumor suppression; it has been found to be involved in embryogenesis, tissue/organ aging, and wound healing. Surprisingly, cellular senescence is also demonstrated to have a tumor progressive role in certain situations. Senescent cells exhibit secretory phenotypes called senescence-associated secretory phenotype (SASP), which secrete a variety of SASP factors including inflammatory cytokines, chemokines, and growth factors, as well as matrix remodeling factors that promote the alteration of neighboring tissue microenvironments. Such SASP factors have been known to drive the mechanisms underlying the pleiotropic features of cellular senescence. In this review, we examine current knowledge of cellular senescence at molecular and cellular levels, with a focus on chronic inflammation and tumor progression. Key Words: senescence, senescence-associated secretory phenotype (SASP), reactive oxygen species (ROS), ionizing radiation, heat shock response (HSR) 1. Introduction Hayflick and Moorhead1) were the first to describe the limited divisions of cells and term this irreversible cell cycle arrest as cellular senescence.
    [Show full text]